These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


645 related items for PubMed ID: 21465801

  • 1. [Translational approach for pharmacogenomics and personalized medicine].
    Zhang W, Zhou HH.
    Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
    [Abstract] [Full Text] [Related]

  • 2. Translational bioinformatics and systems biology approaches for personalized medicine.
    Yan Q.
    Methods Mol Biol; 2010 Jan; 662():167-78. PubMed ID: 20824471
    [Abstract] [Full Text] [Related]

  • 3. Toward personalized medicine in the neuropsychiatric field.
    Wong EH, Fox JC, Ng MY, Lee CM.
    Int Rev Neurobiol; 2011 Jan; 101():329-49. PubMed ID: 22050858
    [Abstract] [Full Text] [Related]

  • 4. Strategies for personalized medicine-based research and implementation in the clinical workflow.
    Lieb W, Völzke H, Pulley JM, Roden DM, Kroemer HK.
    Clin Pharmacol Ther; 2012 Oct; 92(4):443-5. PubMed ID: 22910438
    [Abstract] [Full Text] [Related]

  • 5. The role of bioinformatics in diabetes drug development--and precision medicine.
    Dangi-Garimella S.
    Am J Manag Care; 2014 May; 20(8 Spec No.):E1. PubMed ID: 25617937
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacogenomics, personalized medicine, and heart failure.
    Mestroni L, Taylor MR.
    Discov Med; 2011 Jun; 11(61):551-61. PubMed ID: 21712021
    [Abstract] [Full Text] [Related]

  • 7. [From pharmacogenetics to pharmacogenomics: the start of a new era of personalized medicine in nephrology].
    Zaza G, Granata S, Mangino M, Grandaliano G, Schena FP.
    G Ital Nefrol; 2010 Jun; 27(4):353-66. PubMed ID: 20672232
    [Abstract] [Full Text] [Related]

  • 8. Conference scene: pharmacogenomics: from cell to clinic (part 2).
    Siest G, Medeiros R, Melichar B, Stathopoulou M, Van Schaik RH, Cacabelos R, Abt PM, Monteiro C, Gurwitz D, Queiroz J, Mota-Filipe H, Ndiaye NC, Visvikis-Siest S.
    Pharmacogenomics; 2014 Apr; 15(6):739-44. PubMed ID: 24897282
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic drug monitoring as a component of personalized medicine: applications in pediatric drug development.
    Momper JD, Wagner JA.
    Clin Pharmacol Ther; 2014 Feb; 95(2):138-40. PubMed ID: 24253660
    [Abstract] [Full Text] [Related]

  • 10. Golden Helix Pharmacogenomics Days: educational activities on pharmacogenomics and personalized medicine.
    Squassina A, Severino G, Grech G, Fenech A, Borg J, Patrinos GP.
    Pharmacogenomics; 2012 Apr; 13(5):525-8. PubMed ID: 22462744
    [Abstract] [Full Text] [Related]

  • 11. Personalized pharmacogenomics profiling using whole-genome sequencing.
    Mizzi C, Peters B, Mitropoulou C, Mitropoulos K, Katsila T, Agarwal MR, van Schaik RH, Drmanac R, Borg J, Patrinos GP.
    Pharmacogenomics; 2014 Jun; 15(9):1223-34. PubMed ID: 25141897
    [Abstract] [Full Text] [Related]

  • 12. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
    Albertini L, Siest G, Jeannesson E, Visvikis-Siest S.
    Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430
    [Abstract] [Full Text] [Related]

  • 13. Genomics and drug discovery.
    Lundstrom K.
    Future Med Chem; 2011 Nov; 3(15):1855-8. PubMed ID: 22023028
    [No Abstract] [Full Text] [Related]

  • 14. Dealing with the evidence dilemma in genomics and personalized medicine.
    Khoury MJ.
    Clin Pharmacol Ther; 2010 Jun; 87(6):635-8. PubMed ID: 20485318
    [Abstract] [Full Text] [Related]

  • 15. Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice.
    Squassina A, Manchia M, Manolopoulos VG, Artac M, Lappa-Manakou C, Karkabouna S, Mitropoulos K, Del Zompo M, Patrinos GP.
    Pharmacogenomics; 2010 Aug; 11(8):1149-67. PubMed ID: 20712531
    [Abstract] [Full Text] [Related]

  • 16. Personalized medicine.
    Jain KK.
    Curr Opin Mol Ther; 2002 Dec; 4(6):548-58. PubMed ID: 12596356
    [Abstract] [Full Text] [Related]

  • 17. The application of next-generation sequencing technologies to drug discovery and development.
    Woollard PM, Mehta NA, Vamathevan JJ, Van Horn S, Bonde BK, Dow DJ.
    Drug Discov Today; 2011 Jun; 16(11-12):512-9. PubMed ID: 21440664
    [Abstract] [Full Text] [Related]

  • 18. One size fits one: pharmacogenetics in gastroenterology.
    Porayette P, Flockhart D, Gupta SK.
    Clin Gastroenterol Hepatol; 2014 Apr; 12(4):565-70. PubMed ID: 24486737
    [Abstract] [Full Text] [Related]

  • 19. A piece in the puzzle of personalized medicine.
    Kroemer HK, Meyer zu Schwabedissen HE.
    Clin Pharmacol Ther; 2010 Jan; 87(1):19-20. PubMed ID: 20019696
    [Abstract] [Full Text] [Related]

  • 20. The Affymetrix DMET platform and pharmacogenetics in drug development.
    Deeken J.
    Curr Opin Mol Ther; 2009 Jun; 11(3):260-8. PubMed ID: 19479659
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 33.